241 related articles for article (PubMed ID: 27164662)
1. Determinants of white matter hyperintensity burden in patients with Fabry disease.
Rost NS; Cloonan L; Kanakis AS; Fitzpatrick KM; Azzariti DR; Clarke V; Lourenco CM; Germain DP; Politei JM; Homola GA; Sommer C; Üçeyler N; Sims KB
Neurology; 2016 May; 86(20):1880-6. PubMed ID: 27164662
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease.
Stefaniak JD; Parkes LM; Parry-Jones AR; Potter GM; Vail A; Jovanovic A; Smith CJ
Neurology; 2018 Oct; 91(15):e1413-e1422. PubMed ID: 30209238
[TBL] [Abstract][Full Text] [Related]
3. Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset.
Zhang CR; Cloonan L; Fitzpatrick KM; Kanakis AS; Ayres AM; Furie KL; Rosand J; Rost NS
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):649-54. PubMed ID: 25576348
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.
Fellgiebel A; Gartenschläger M; Wildberger K; Scheurich A; Desnick RJ; Sims K
Cerebrovasc Dis; 2014; 38(6):448-56. PubMed ID: 25502511
[TBL] [Abstract][Full Text] [Related]
5. FLAIR Vascular Hyperintensity is a Surrogate of Collateral Flow and Leukoaraiosis in Patients With Acute Stroke Due to Proximal Artery Occlusion.
Karadeli HH; Giurgiutiu DV; Cloonan L; Fitzpatrick K; Kanakis A; Ozcan ME; Schwamm LH; Rost NS
J Neuroimaging; 2016; 26(2):219-23. PubMed ID: 26250448
[TBL] [Abstract][Full Text] [Related]
6. Determinants of white matter hyperintensity volume in patients with acute ischemic stroke.
Rost NS; Rahman R; Sonni S; Kanakis A; Butler C; Massasa E; Cloonan L; Gilson A; Delgado P; Chang Y; Biffi A; Jimenez-Conde J; Besanger A; Silva G; Smith EE; Rosand J; Furie KL
J Stroke Cerebrovasc Dis; 2010 May; 19(3):230-235. PubMed ID: 20434052
[TBL] [Abstract][Full Text] [Related]
7. Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.
Cloonan L; Fitzpatrick KM; Kanakis AS; Furie KL; Rosand J; Rost NS
Atherosclerosis; 2015 May; 240(1):149-53. PubMed ID: 25795555
[TBL] [Abstract][Full Text] [Related]
8. Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.
Phyu P; Merwick A; Davagnanam I; Bolsover F; Jichi F; Wheeler-Kingshott C; Golay X; Hughes D; Cipolotti L; Murphy E; Lachmann RH; Werring DJ
Neurology; 2018 Apr; 90(16):e1379-e1385. PubMed ID: 29661900
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Cerebral Microbleeds in Patients with Fabry Disease.
Kono Y; Wakabayashi T; Kobayashi M; Ohashi T; Eto Y; Ida H; Iguchi Y
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1320-5. PubMed ID: 26987491
[TBL] [Abstract][Full Text] [Related]
10. White matter hyperintensity burden in acute stroke patients differs by ischemic stroke subtype.
Giese AK; Schirmer MD; Dalca AV; Sridharan R; Donahue KL; Nardin M; Irie R; McIntosh EC; Mocking SJT; Xu H; Cole JW; Giralt-Steinhauer E; Jimenez-Conde J; Jern C; Kleindorfer DO; Lemmens R; Wasselius J; Lindgren A; Rundek T; Sacco RL; Schmidt R; Sharma P; Slowik A; Thijs V; Worrall BB; Woo D; Kittner SJ; McArdle PF; Mitchell BD; Rosand J; Meschia JF; Wu O; Golland P; Rost NS;
Neurology; 2020 Jul; 95(1):e79-e88. PubMed ID: 32493718
[TBL] [Abstract][Full Text] [Related]
11. Development and clinical consequences of white matter lesions in Fabry disease: a systematic review.
Körver S; Vergouwe M; Hollak CEM; van Schaik IN; Langeveld M
Mol Genet Metab; 2018 Nov; 125(3):205-216. PubMed ID: 30213639
[TBL] [Abstract][Full Text] [Related]
12. Brainstem leukoaraiosis independently predicts poor outcome after ischemic stroke.
Giralt-Steinhauer E; Medrano S; Soriano-Tárraga C; Mola-Caminal M; Rasal R; Cuadrado-Godia E; Rodríguez-Campello A; Ois A; Capellades J; Jimenez-Conde J; Roquer J
Eur J Neurol; 2018 Aug; 25(8):1086-1092. PubMed ID: 29660221
[TBL] [Abstract][Full Text] [Related]
13. Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden.
Li Y; Li M; Zhang X; Shi Q; Yang S; Fan H; Qin W; Yang L; Yuan J; Jiang T; Hu W
J Neurol; 2017 Jul; 264(7):1474-1481. PubMed ID: 28653212
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensity volume correlates with matrix metalloproteinase-2 in acute ischemic stroke.
Corbin ZA; Rost NS; Lorenzano S; Kernan WN; Parides MK; Blumberg JB; Milbury PE; Arai K; Hartdegen SN; Lo EH; Feske SK; Furie KL
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1300-6. PubMed ID: 24439130
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.
Green NS; Bhatia M; Griffith EY; Qureshi M; Briamonte C; Savone M; Sands S; Lee MT; Lignelli A; Brickman AM
Biol Blood Marrow Transplant; 2017 Apr; 23(4):670-676. PubMed ID: 28089760
[TBL] [Abstract][Full Text] [Related]
16. Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients.
Rist PM; Buring JE; Rexrode KM; Cook NR; Rost NS
Eur J Epidemiol; 2019 Oct; 34(10):957-965. PubMed ID: 31399938
[TBL] [Abstract][Full Text] [Related]
17. White Matter Hyperintensity-Adjusted Critical Infarct Thresholds to Predict a Favorable 90-Day Outcome.
Patti J; Helenius J; Puri AS; Henninger N
Stroke; 2016 Oct; 47(10):2526-33. PubMed ID: 27633020
[TBL] [Abstract][Full Text] [Related]
18. Brain MRI findings in children and adolescents with Fabry disease.
Marchesoni C; Cisneros E; Pfister P; Yáñez P; Rollan C; Romero C; Kisinovsky I; Rattagan L; León Cejas L; Pardal A; Sevlever G; Reisin R
J Neurol Sci; 2018 Dec; 395():131-134. PubMed ID: 30316069
[TBL] [Abstract][Full Text] [Related]
19. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.
Jeerakathil T; Wolf PA; Beiser A; Massaro J; Seshadri S; D'Agostino RB; DeCarli C
Stroke; 2004 Aug; 35(8):1857-61. PubMed ID: 15218158
[TBL] [Abstract][Full Text] [Related]
20. White matter hyperintensity lesion burden is associated with the infarct volume and 90-day outcome in small subcortical infarcts.
Helenius J; Mayasi Y; Henninger N
Acta Neurol Scand; 2017 May; 135(5):585-592. PubMed ID: 27573379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
